{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T08:59:54Z","timestamp":1775293194472,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,10,1]]},"DOI":"10.1093\/jac\/dkh408","type":"journal-article","created":{"date-parts":[[2004,9,9]],"date-time":"2004-09-09T00:13:43Z","timestamp":1094688823000},"page":"722-729","source":"Crossref","is-referenced-by-count":25,"title":["Effect ofn-octanesulphonylacetamide (OSA) on ATP and protein expression in Mycobacterium bovis BCG"],"prefix":"10.1093","volume":"54","author":[{"given":"Nicole M.","family":"Parrish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiew G.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minerva A.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig A.","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,10]]},"reference":[{"key":"key\n\t\t\t\t20171010173425_R1","unstructured":"Netto, E., Dye, C. & Raviglione, M. (1999). Progress in global tuberculosis control 1995\u20131996, with emphasis on 22 high-incidence countries. Global Monitoring and Surveillance Project. International Journal of Tuberculosis and Lung Disease3, 310\u201320."},{"key":"key\n\t\t\t\t20171010173425_R2","unstructured":"Centers for Disease Control and Prevention. (1993). Estimates of future global tuberculosis morbidity and mortality. MMWR Morbidity and Mortality Weekly Report42, 961\u20134."},{"key":"key\n\t\t\t\t20171010173425_R3","unstructured":"Centers for Disease Control and Prevention. (1996). Tuberculosis morbidity\u2014United States 1995. MMWR Morbidity and Mortality Weekly Report45, 365\u201370."},{"key":"key\n\t\t\t\t20171010173425_R4","unstructured":"Centers for Disease Control and Prevention. (1998). Development of new vaccines for tuberculosis. Recommendations of the Advisory Council for the Elimination of Tuberculosis (ACET). MMWR Morbidity and Mortality Weekly Report: Recommendations and Reports47, 1\u20136."},{"key":"key\n\t\t\t\t20171010173425_R5","unstructured":"World Health Organization. Global Tuberculosis Control. WHO Report 2000. WHO\/CDS\/TB\/2000 275. WHO, Geneva, Switzerland."},{"key":"key\n\t\t\t\t20171010173425_R6","unstructured":"De Cock, K. & Chaisson, R. (1999). Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. International Journal of Tuberculosis and Lung Disease3, 457\u201365."},{"key":"key\n\t\t\t\t20171010173425_R7","unstructured":"Perlman, D., El-Helou, P. & Samomon, N. (1999). Tuberculosis in patients with human immunodeficiency virus infection. Seminars in Respiratory Infections14, 344\u201352."},{"key":"key\n\t\t\t\t20171010173425_R8","doi-asserted-by":"crossref","unstructured":"Dooley, S., Jarvis, W., Martone, W. et al. (1992). Multidrug-resistant tuberculosis. Annals of Internal Medicine117, 257\u20139.","DOI":"10.7326\/0003-4819-117-3-257"},{"key":"key\n\t\t\t\t20171010173425_R9","doi-asserted-by":"crossref","unstructured":"Frieden, T., Sterling, T., Pablos-Mendez, A. et al. (1993). The emergence of drug-resistant tuberculosis in New York City. New England Journal of Medicine328, 521\u20136.","DOI":"10.1056\/NEJM199302253280801"},{"key":"key\n\t\t\t\t20171010173425_R10","unstructured":"Pablos-Mendez, A., Raviglione, M., Laszlo, A. et al. (1998). Global surveillance for anti-tuberculosis-drug resistance, 1994\u20131998. World Health Organization\u2013International Union Against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. New England Journal of Medicine338, 1998, 1641\u20139."},{"key":"key\n\t\t\t\t20171010173425_R11","doi-asserted-by":"crossref","unstructured":"Mitchison, D. A. (1992). The Garrod Lecture: Understanding the chemotherapy of tuberculosis, current problems. Journal of Antimicrobial Chemotherapy29, 477\u201393.","DOI":"10.1093\/jac\/29.5.477"},{"key":"key\n\t\t\t\t20171010173425_R12","unstructured":"World Health Organization\u2013International Union Against Tuberculosis and Lung Disease. (1997). Anti-Tuberculosis Drug Resistance in the World. Report No. 2. WHO\u2013IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. WHO\/CDS\/TB\/2000.278. WHO\u2013IUATLD, Geneva, Switzerland."},{"key":"key\n\t\t\t\t20171010173425_R13","doi-asserted-by":"crossref","unstructured":"Fung-Tomc, J., Minassian, B., Kolek, B. et al. (2000). In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin. Journal of Antimicrobial Chemotherapy45, 437\u201346.","DOI":"10.1093\/jac\/45.4.437"},{"key":"key\n\t\t\t\t20171010173425_R14","doi-asserted-by":"crossref","unstructured":"Ji, B., Lounis, N., Truffot-Pernot, C. et al. (1995). In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy39, 1341\u20134.","DOI":"10.1128\/AAC.39.6.1341"},{"key":"key\n\t\t\t\t20171010173425_R15","doi-asserted-by":"crossref","unstructured":"Miyazaki, E., Miyazaki, M., Chen, J. et al. (1999). Moxifloxacin (Bayer 12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis. Antimicrobial Agents and Chemotherapy43, 85\u20139.","DOI":"10.1128\/AAC.43.1.85"},{"key":"key\n\t\t\t\t20171010173425_R16","doi-asserted-by":"crossref","unstructured":"Cynamon, M., Klemens, S., Sharp, C. et al. (1999). Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model. Antimicrobial Agents and Chemotherapy43, 1189\u201391.","DOI":"10.1128\/AAC.43.5.1189"},{"key":"key\n\t\t\t\t20171010173425_R17","doi-asserted-by":"crossref","unstructured":"Stover, C., Warrener, P., Van Devanter, D. et al. (2000). A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature405, 962\u20136.","DOI":"10.1038\/35016103"},{"key":"key\n\t\t\t\t20171010173425_R18","doi-asserted-by":"crossref","unstructured":"Jones, P., Parrish, N., Houston, T. et al. (2000). A new class of antituberculosis agents. Journal of Medicinal Chemistry43, 3304\u201314.","DOI":"10.1021\/jm000149l"},{"key":"key\n\t\t\t\t20171010173425_R19","doi-asserted-by":"crossref","unstructured":"Parrish, N., Townsend, C., Jones, P. et al. (2001). In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis. Antimicrobial Agents and Chemotherapy45, 1143\u201350.","DOI":"10.1128\/AAC.45.4.1143-1150.2001"},{"key":"key\n\t\t\t\t20171010173425_R20","doi-asserted-by":"crossref","unstructured":"Mariani, F., Capelli, G., Riccardi, G. et al. (2000). Mycobacterium tuberculosis H37Rv comparative gene-expression analysis in synthetic medium and human macrophage. Gene253, 281\u201391.","DOI":"10.1016\/S0378-1119(00)00249-3"},{"key":"key\n\t\t\t\t20171010173425_R21","unstructured":"Colston, M. & Lee, Y. (1985). Measurement of ATP generation and decay in Mycobacterium leprae in vitro. Journal of General Microbiology131, 3331\u20137."},{"key":"key\n\t\t\t\t20171010173425_R22","unstructured":"Parrish, N. (1999). Characterization of fatty acid synthesis in mycobacteria as an approach to elucidate potential antimycobacterial chemotherapeutic agents, PhD Thesis. Johns Hopkins University, Baltimore, MD, USA."},{"key":"key\n\t\t\t\t20171010173425_R23","doi-asserted-by":"crossref","unstructured":"Parrish, N., Kuhajda, F., Heine, H. et al. (1999). Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis. Journal of Antimicrobial Chemotherapy43, 219\u201326.","DOI":"10.1093\/jac\/43.2.219"},{"key":"key\n\t\t\t\t20171010173425_R24","doi-asserted-by":"crossref","unstructured":"Mdluli, D., Slayden, R., Zhu, Y. et al. (1998). Inhibition of a Mycobacterium tuberculosis \u03b2-ketoacyl ACP synthase by isoniazid. Science280, 1607\u201310.","DOI":"10.1126\/science.280.5369.1607"},{"key":"key\n\t\t\t\t20171010173425_R25","doi-asserted-by":"crossref","unstructured":"Beauvieux, M., Tissier, P., Couzigou, P. et al. (2002). Ethanol perfusion increases the yield of oxidative phosphorylation in isolated liver of fed rats. Biochimica et Biophysica Acta1570, 135\u201340.","DOI":"10.1016\/S0304-4165(02)00187-3"},{"key":"key\n\t\t\t\t20171010173425_R26","unstructured":"Bettelheim, F. & March, J. (1991). Alcohols, phenols, ethers, and halides. In Advances in Enzymology (Bettelheim, F. & March, J. Eds), pp. 1\u201384. John Wiley and Sons, New York, USA."},{"key":"key\n\t\t\t\t20171010173425_R27","doi-asserted-by":"crossref","unstructured":"Caviston, T., Ketchum, C., Sorgen, P. et al. (1998). Identification of an uncoupling mutation affecting the b subunit of F1F0 ATP synthase in Escherichia coli. FEBS Letters429, 201\u20136.","DOI":"10.1016\/S0014-5793(98)00597-3"},{"key":"key\n\t\t\t\t20171010173425_R28","doi-asserted-by":"crossref","unstructured":"Dmitriev, O., Jones, P., Jiang, W. et al. (1999). Structure of the membrane domain of subunit b of the Escherichia coli F0F1 ATP synthase. Journal of Biological Chemistry274, 15598\u2013604.","DOI":"10.1074\/jbc.274.22.15598"},{"key":"key\n\t\t\t\t20171010173425_R29","doi-asserted-by":"crossref","unstructured":"Dunn, S. (1992). The polar domain of the b subunit of Escherichia coli F1F0-ATPase forms an elongated dimer that interacts with the F1 sector. Journal of Biological Chemistry267, 7630\u20136.","DOI":"10.1016\/S0021-9258(18)42562-8"},{"key":"key\n\t\t\t\t20171010173425_R30","doi-asserted-by":"crossref","unstructured":"Dunn, S., McLachlin, D. & Revington, M. (2000). The second stalk of Escherichia coli ATP synthase. Biochimica et Biophysica Acta1458, 356\u201363.","DOI":"10.1016\/S0005-2728(00)00086-4"},{"key":"key\n\t\t\t\t20171010173425_R31","doi-asserted-by":"crossref","unstructured":"Jones, P., Hermolin, J., Jiang, W. et al. (2000). Insights into the rotary catalytic mechanism of F0F1 ATP synthase from the cross-linking of subunits b and c in the Escherichia coli enzyme. Journal of Biological Chemistry275, 31340\u20136.","DOI":"10.1074\/jbc.M003687200"},{"key":"key\n\t\t\t\t20171010173425_R32","doi-asserted-by":"crossref","unstructured":"McLachlin, D. & Dunn, S. (1997). Dimerization interactions of the b subunit of the Escherichia coli F1F0-ATPase. Journal of Biological Chemistry272, 21233\u20139.","DOI":"10.1074\/jbc.272.34.21233"},{"key":"key\n\t\t\t\t20171010173425_R33","doi-asserted-by":"crossref","unstructured":"Struglics, A., Fredlund, K., Moller, I. et al. (1998). Two subunits of the F0F1-ATPase are phosphorylated in the inner mitochondrial membrane. Biochemical and Biophysical Research Communications243, 664\u20138.","DOI":"10.1006\/bbrc.1998.8151"},{"key":"key\n\t\t\t\t20171010173425_R34","doi-asserted-by":"crossref","unstructured":"Stewart, G., Wernisch, L., Stabler, R. et al. (2002). Dissection of the heat-shock response in Mycobacterium tuberculosis using mutants and microarrays. Microbiology148, 3129\u201338.","DOI":"10.1099\/00221287-148-10-3129"},{"key":"key\n\t\t\t\t20171010173425_R35","doi-asserted-by":"crossref","unstructured":"Manganelli, R., Voskuil, M., Schoolnik, G. et al. (2001). The Mycobacterium tuberculosis ECF sigma factor \u03c3E: role in global gene expression and survival in macrophages. Molecular Microbiology41, 423\u201337.","DOI":"10.1046\/j.1365-2958.2001.02525.x"},{"key":"key\n\t\t\t\t20171010173425_R36","doi-asserted-by":"crossref","unstructured":"Ackerman, S. (2002). Atp11p and Atp12p are chaperones for F1-ATPase biogenesis in mitochondria. Biochimica et Biophysica Acta1555, 101\u20135.","DOI":"10.1016\/S0005-2728(02)00262-1"},{"key":"key\n\t\t\t\t20171010173425_R37","doi-asserted-by":"crossref","unstructured":"Jakob, U., Muse, W., Eser, M. et al. (1999). Chaperone activity with a redox switch. Cell96, 341\u201352.","DOI":"10.1016\/S0092-8674(00)80547-4"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/54\/4\/722\/2294553\/dkh408.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T15:43:11Z","timestamp":1624635791000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/54\/4\/722\/763449\/Effect-ofnoctanesulphonylacetamide-OSA-on-ATP-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,1]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2004,10]]},"published-print":{"date-parts":[[2004,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkh408","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,10]]},"published":{"date-parts":[[2004,10,1]]}}}